Certara Investor Day Presentation Deck
Certara at a glance
BUSINESS
20+ Year
History of innovation
1,100+ Employees(1)
350+ with Ph.D.s,
Pharm.D.s and M.D.s
15 Acquisitions
Track record of accretive,
complementary
acquisitions
(1) As of 11/30/2021
(2) Market research reports from Grand View and SpendEdge
(3) Customer data as of 12/31/2020
(4) See Appendix for reconciliation tables
●
●
●
END-TO-END PLATFORM
Software
●
Biosimulation
Regulatory & compliance
Market access
Technology-Driven Services
• Drug discovery & development
with biosimulation
• Regulatory science
Market access
$13B TAM growing at
12-16% CAGR(²)
CUSTOMERS (3)
1,650+
Customers across
61 countries
10+ Year
Average tenure
for top 30 customers
261 customers with
ACV > $100,000
53 customers with
ACV > $1M
2021 Q1-Q3 FINANCIALS
$210.8M Revenue
18% YoY Growth
$75.5M
Adjusted EBITDA (4)
15% YoY Growth
36% Adjusted EBITDA
Margin
Net Loss ($3.6M)
PY $5.1M
5
CERTARAView entire presentation